Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II crossover trial of PD-protec in peritoneal dialysis patients
2013-000400-42Phase 2Completed
- Sponsor
- Zytoprotec
- Start
- Mar 2014
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of PD-protec in end-stage kidney disease (ESKD) (2 arms), sponsored by Zytoprotec. Primary endpoint: Peritoneal health. Started Mar 2014; status: completed.
02
Drugs
PD-protec
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2013-000400-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000400-42.